Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Acadia Pharmaceutica (ACAD)

Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,932,673
  • Shares Outstanding, K 165,221
  • Annual Sales, $ 726,440 K
  • Annual Income, $ -61,290 K
  • 60-Month Beta 0.38
  • Price/Sales 4.09
  • Price/Cash Flow N/A
  • Price/Book 6.41
Trade ACAD with:

Options Overview Details

View History
  • Implied Volatility 76.80% ( -7.64%)
  • Historical Volatility 35.10%
  • IV Percentile 92%
  • IV Rank 75.32%
  • IV High 95.33% on 02/15/24
  • IV Low 20.22% on 07/02/24
  • Put/Call Vol Ratio 0.16
  • Today's Volume 2,905
  • Volume Avg (30-Day) 957
  • Put/Call OI Ratio 0.51
  • Today's Open Interest 21,458
  • Open Int (30-Day) 18,199

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate 0.16
  • Number of Estimates 8
  • High Estimate 0.26
  • Low Estimate 0.09
  • Prior Year 0.01
  • Growth Rate Est. (year over year) +1,500.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.28 +15.18%
on 06/26/24
18.93 -7.03%
on 07/17/24
+2.30 (+15.03%)
since 06/21/24
3-Month
14.55 +20.96%
on 06/10/24
18.93 -7.03%
on 07/17/24
+0.61 (+3.59%)
since 04/22/24
52-Week
14.55 +20.96%
on 06/10/24
32.59 -46.00%
on 12/22/23
-13.20 (-42.86%)
since 07/21/23

Most Recent Stories

More News
Acadia: Q1 Earnings Snapshot

Acadia: Q1 Earnings Snapshot

ACAD : 17.60 (-0.85%)
Stock Futures Ignore Higher-Than-Expected US Inflation Report

March S&P 500 E-Mini futures (ESH24) are trending up +0.30% this morning as market participants awaited the all-important U.S. consumer inflation report that could shed light on the Federal Reserve’s...

ESH24 : 5,101.67s (-1.01%)
BA : 181.00 (+0.74%)
MRVL : 67.97 (+2.20%)
AMD : 153.85 (+1.50%)
BALY : 13.80 (+1.92%)
WCH.D.DX : 101.550 (+1.95%)
ORCL : 139.70 (+0.82%)
ACAD : 17.60 (-0.85%)
MTN : 180.26 (+0.37%)
HRTG : 7.06 (-5.49%)
CVNA : 132.30 (+1.72%)
Acadia: Q4 Earnings Snapshot

Acadia: Q4 Earnings Snapshot

ACAD : 17.60 (-0.85%)
Acadia: Q3 Earnings Snapshot

Acadia: Q3 Earnings Snapshot

ACAD : 17.60 (-0.85%)
Why Acadia Pharmaceuticals Stock Is Rising Today

An analyst upgrade is sparking a rally in the drugmaker's shares today.

JPM : 210.20 (+0.20%)
ACAD : 17.60 (-0.85%)
2 Growth Stocks I'd Buy on the Dip

These two growth stocks could be worthwhile buy-and-holds.

BUD : 61.49 (+1.72%)
ACAD : 17.60 (-0.85%)
TLRY : 1.8407 (+2.83%)
2 Supercharged Growth Stocks Billionaires Can't Stop Buying

A top hedge fund has been steadily buying these two growth stocks in 2023.

PFE : 30.06 (+0.30%)
ACAD : 17.60 (-0.85%)
ROIV : 11.00 (-0.99%)
Betting Big On Biotech: Six Undervalued Biotech Stocks To Keep On Your Radar

Following a tumultuous performance year, the biotechnology sector is steadily regaining traction once again, with investors starting to reveal a somewhat bullish sentiment despite having to endure macroeconomic...

HALO : 54.13 (+0.17%)
KNSA : 20.85 (-1.79%)
ACAD : 17.60 (-0.85%)
HRMY : 32.04 (-1.90%)
AMPH : 39.61 (-0.35%)
INCY : 65.90 (+0.05%)
AGEN : 6.03 (+0.70%)
NVS : 107.90 (+1.67%)
PFE : 30.06 (+0.30%)
SGEN : 228.74 (-0.07%)
MRK : 125.80 (+0.02%)
RXDX : 199.92 (+0.09%)
Can This Red-Hot Biotech Stock Keep Beating the Broader Markets?

This biotech stock has been on fire in 2023.

ACAD : 17.60 (-0.85%)
This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street

This small-cap biotech might be a hidden gem.

ACAD : 17.60 (-0.85%)
STOK : 13.58 (-0.37%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Acadia Pharmaceuticals Inc. is a biopharmaceutical company focused on developing innovative medicines to address the unmet medical needs in central nervous system (CNS) disorders. The company's sole marketed drug Nuplazid (pimavanserin) is the first and the only FDA-approved treatment for hallucinations...

See More

Key Turning Points

3rd Resistance Point 18.70
2nd Resistance Point 18.48
1st Resistance Point 18.12
Last Price 17.60
1st Support Level 17.53
2nd Support Level 17.31
3rd Support Level 16.94

See More

52-Week High 32.59
Fibonacci 61.8% 25.70
Fibonacci 50% 23.57
Fibonacci 38.2% 21.44
Last Price 17.60
52-Week Low 14.55

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar